Filing Flows › Inogen (INGN) › Recalls, complaints & regulation
Inogen (INGN): clinical trials
Inogen (INGN) beyond its filings: 1 active clinical trial.
Inogen's latest quarter
Inogen, Q2 2026: revenue $95.1M (+3% year over year), operating margin -5.4%, net loss $3.9M, operating cash flow $2.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Inogen have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.